Pub Date : 2024-08-01Epub Date: 2022-12-04DOI: 10.1177/22925503221141707
Moaath M Saggaf, Kathy Liu, George Ho, Emily E Anastakis, Heather Baltzer
Purpose: The aim of this study was to assess the sex differences in enrollment into clinical trials for Dupuytren's disease (DD), treatment efficacy, and complications. Methods: Three databases were searched; Ovid MEDLINE, Ovid EMBASE, and EBSCO CINAHL. Included studies were clinical trials on adult patients with DD. Exclusion criteria were non-English studies and other study designs. Two independent reviewers completed abstract screening, full-text review, and data extraction. The number and percentage of studies that reported ad hoc analyses for sex differences in treatment efficacy, tolerability, and complications were reported. A meta-analysis was performed on the proportion of female participants enrolled in clinical trials for DD. Results: A total of 3172 references were screened, and 59 studies were identified for full-text review. We identified 28 clinical trials for DD of which none reported secondary analyses for sex differences. Only 2 trials discussed sex differences in complications, and one trial reported sex differences in tolerability. The proportion of female participants in the meta-analysis was 19.5% [95% CI: 16.1-23.0%]. Conclusion: Sex differences in the clinical trials for DD are not widely considered in clinical trials despite their critical role. Males and females do not have equal representation in clinical trials for DD. Future studies should account for sex differences in the design and the analysis of clinical trials.
{"title":"Sex Difference in the Treatment of Dupuytren's Disease: A Systematic Review and Meta-Analysis of Clinical Trials.","authors":"Moaath M Saggaf, Kathy Liu, George Ho, Emily E Anastakis, Heather Baltzer","doi":"10.1177/22925503221141707","DOIUrl":"10.1177/22925503221141707","url":null,"abstract":"<p><p><b>Purpose:</b> The aim of this study was to assess the sex differences in enrollment into clinical trials for Dupuytren's disease (DD), treatment efficacy, and complications. <b>Methods:</b> Three databases were searched; Ovid MEDLINE, Ovid EMBASE, and EBSCO CINAHL. Included studies were clinical trials on adult patients with DD. Exclusion criteria were non-English studies and other study designs. Two independent reviewers completed abstract screening, full-text review, and data extraction. The number and percentage of studies that reported ad hoc analyses for sex differences in treatment efficacy, tolerability, and complications were reported. A meta-analysis was performed on the proportion of female participants enrolled in clinical trials for DD. <b>Results:</b> A total of 3172 references were screened, and 59 studies were identified for full-text review. We identified 28 clinical trials for DD of which none reported secondary analyses for sex differences. Only 2 trials discussed sex differences in complications, and one trial reported sex differences in tolerability. The proportion of female participants in the meta-analysis was 19.5% [95% CI: 16.1-23.0%]. <b>Conclusion:</b> Sex differences in the clinical trials for DD are not widely considered in clinical trials despite their critical role. Males and females do not have equal representation in clinical trials for DD. Future studies should account for sex differences in the design and the analysis of clinical trials.</p>","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45237559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-26DOI: 10.1177/22925503241264839
Zeynep Altuntaş, Moath Zuhour, Orkun Uyanık
Objectives: Recent studies have started to question the need for acellular dermal matrix (ADM) in immediate implant-based prepectoral breast reconstruction. However, most of the patients in these studies did not receive postoperative radiotherapy. In this study, it was aimed to investigate the major complication rate after immediate prepectoral breast reconstruction without the use of ADM and to find the optimal cutoff value of the mastectomy flap thickness. Methods: Patients who underwent immediate prepectoral breast reconstruction and received postoperative radiotherapy between 2020 and 2022 were included in this retrospective study. The correlation between mastectomy flap thickness and major complications was investigated. Results: A total of 77 patients, corresponding to 81 breasts were included in this study. Major complications were encountered in 18 (22%) breasts. The thickness of mastectomy flaps ranged from 0.31 mm to 1.2 cm, with an average thickness of 6.6 ± 2.1 mm. No capsule contracture was encountered in any of the patients during the follow-up period (21.1 ± 4.3 M). A flap thickness of ≤5.5 mm is the cutoff value for developing major complications in patients who will receive radiotherapy ( P < .05). Conclusion: Immediate prepectoral breast reconstruction without using ADM is a reliable and safe method for breast reconstruction. However, if radiotherapy is planned, care must be taken when mastectomy flap thickness is equal or below 5.5 mm to avoid major complications. Prepectoral reconstruction with transverse mastectomy incision provides the ability to complete the reconstruction in a single session with a high cost-effective way.
{"title":"The Effect of Flap Thickness on Major Complications of Prepectoral Breast Reconstruction Without Using ADM in Radiotherapy Patients","authors":"Zeynep Altuntaş, Moath Zuhour, Orkun Uyanık","doi":"10.1177/22925503241264839","DOIUrl":"https://doi.org/10.1177/22925503241264839","url":null,"abstract":"Objectives: Recent studies have started to question the need for acellular dermal matrix (ADM) in immediate implant-based prepectoral breast reconstruction. However, most of the patients in these studies did not receive postoperative radiotherapy. In this study, it was aimed to investigate the major complication rate after immediate prepectoral breast reconstruction without the use of ADM and to find the optimal cutoff value of the mastectomy flap thickness. Methods: Patients who underwent immediate prepectoral breast reconstruction and received postoperative radiotherapy between 2020 and 2022 were included in this retrospective study. The correlation between mastectomy flap thickness and major complications was investigated. Results: A total of 77 patients, corresponding to 81 breasts were included in this study. Major complications were encountered in 18 (22%) breasts. The thickness of mastectomy flaps ranged from 0.31 mm to 1.2 cm, with an average thickness of 6.6 ± 2.1 mm. No capsule contracture was encountered in any of the patients during the follow-up period (21.1 ± 4.3 M). A flap thickness of ≤5.5 mm is the cutoff value for developing major complications in patients who will receive radiotherapy ( P < .05). Conclusion: Immediate prepectoral breast reconstruction without using ADM is a reliable and safe method for breast reconstruction. However, if radiotherapy is planned, care must be taken when mastectomy flap thickness is equal or below 5.5 mm to avoid major complications. Prepectoral reconstruction with transverse mastectomy incision provides the ability to complete the reconstruction in a single session with a high cost-effective way.","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141782668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-23DOI: 10.1177/22925503241263354
Pranit R. Sunkara, Lauren E. Powell, Joseph D. Quick, Joel J. Stanek, Ashish Y. Mahajan
{"title":"A Readability Analysis of Online Patient Education Materials Regarding Fibula Free Flap Surgery","authors":"Pranit R. Sunkara, Lauren E. Powell, Joseph D. Quick, Joel J. Stanek, Ashish Y. Mahajan","doi":"10.1177/22925503241263354","DOIUrl":"https://doi.org/10.1177/22925503241263354","url":null,"abstract":"","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141782671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-23DOI: 10.1177/22925503241264832
Jeffrey Chen, Brendan K. Tao, Shihyun Park, Esta Bovill
Introduction: Personal statements can be decisive in Canadian residency applications. With the rise in AI technology, ethical concerns regarding authenticity and originality become more pressing. This study explores the capability of ChatGPT in producing personal statements for plastic surgery residency that match the quality of statements written by successful applicants. Methods: ChatGPT was utilized to generate a cohort of personal statements for CaRMS (Canadian Residency Matching Service) to compare with previously successful Plastic Surgery applications. Each AI-generated and human-written statement was randomized and anonymized prior to assessment. Two retired members of the plastic surgery residency selection committee from the University of British Columbia, evaluated these on a 0 to 10 scale and provided a binary response judging whether each statement was AI or human written. Statistical analysis included Welch 2-sample t tests and Cohen's Kappa for agreement. Results: Twenty-two personal statements (11 AI-generated by ChatGPT and 11 human-written) were evaluated. The overall mean scores were 7.48 (SD 0.932) and 7.68 (SD 0.716), respectively, with no significant difference between AI and human groups ( P = .4129). The average accuracy in distinguishing between human and AI letters was 65.9%. The Cohen's Kappa value was 0.374. Conclusions: ChatGPT can generate personal statements for plastic surgery residency applications with quality indistinguishable from human-written counterparts, as evidenced by the lack of significant scoring difference and moderate accuracy in discrimination by experienced surgeons. These findings highlight the evolving role of AI and the need for updated evaluative criteria or guidelines in the residency application process.
{"title":"Can ChatGPT Fool the Match? Artificial Intelligence Personal Statements for Plastic Surgery Residency Applications: A Comparative Study","authors":"Jeffrey Chen, Brendan K. Tao, Shihyun Park, Esta Bovill","doi":"10.1177/22925503241264832","DOIUrl":"https://doi.org/10.1177/22925503241264832","url":null,"abstract":"Introduction: Personal statements can be decisive in Canadian residency applications. With the rise in AI technology, ethical concerns regarding authenticity and originality become more pressing. This study explores the capability of ChatGPT in producing personal statements for plastic surgery residency that match the quality of statements written by successful applicants. Methods: ChatGPT was utilized to generate a cohort of personal statements for CaRMS (Canadian Residency Matching Service) to compare with previously successful Plastic Surgery applications. Each AI-generated and human-written statement was randomized and anonymized prior to assessment. Two retired members of the plastic surgery residency selection committee from the University of British Columbia, evaluated these on a 0 to 10 scale and provided a binary response judging whether each statement was AI or human written. Statistical analysis included Welch 2-sample t tests and Cohen's Kappa for agreement. Results: Twenty-two personal statements (11 AI-generated by ChatGPT and 11 human-written) were evaluated. The overall mean scores were 7.48 (SD 0.932) and 7.68 (SD 0.716), respectively, with no significant difference between AI and human groups ( P = .4129). The average accuracy in distinguishing between human and AI letters was 65.9%. The Cohen's Kappa value was 0.374. Conclusions: ChatGPT can generate personal statements for plastic surgery residency applications with quality indistinguishable from human-written counterparts, as evidenced by the lack of significant scoring difference and moderate accuracy in discrimination by experienced surgeons. These findings highlight the evolving role of AI and the need for updated evaluative criteria or guidelines in the residency application process.","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141782670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-23DOI: 10.1177/22925503241265299
Eylon J. Arbel, Alyssa D. Reese, Raymond Richards, Simran Singh, Aidan W. O’Shea, Finn Hennig, David Abramowitz
Introduction: Penile amputation is a rare urological emergency with varying etiologies, ranging from psychiatric disorders to traumatic injuries, and requires precise microsurgical replantation techniques to restore function and appearance. The popularization of microsurgery has greatly improved outcomes by enabling accurate vascular and nerve reattachments, which are crucial for erectile function and sensation. This comprehensive study reviews advancements in microsurgical penile replantation, perioperative, and postoperative care, focusing on the nuances of surgical interventions and potential complications such as ischemia and necrosis. Methods: The PubMed, EMBASE, and Cochrane databases, were queried for studies published between 2015 and 2023 that discussed preoperative conditions, surgical techniques, and postoperative outcomes in penile replantation cases. Resulting studies that reported preoperative and postoperative outcomes of at least one case of penile replantation after amputation were included. Case parameters of interest were then extracted and categorized to determine the most common complications as well as solutions utilized in penile replantation. Results: Our findings from 46 cases across 37 studies revealed a common occurrence of postoperative necrosis (56.5%) and highlighted the importance of timely vascular reconnection and innovative surgical strategies to manage complications. Three cases were complicated by scrotal hematomas and 23 cases reported at least one psychiatric comorbidity. Some innovative solutions mentioned include hyperbaric oxygen therapy, laser angiography, leech therapy, PDE inhibitors, and penile splints. Conclusion: The outcomes suggest a critical need for standardized protocols and further research into optimizing techniques and therapies to enhance the success rates as well as quality of life post-replantation. This review aims to guide future practices and encourage collaborative efforts to refine the complex microsurgical procedures involved in penile replantation.
{"title":"Penile Replantation: A Review of Microsurgical Techniques, Patient Outcomes, and Solutions to Complex Reconstructive Challenges","authors":"Eylon J. Arbel, Alyssa D. Reese, Raymond Richards, Simran Singh, Aidan W. O’Shea, Finn Hennig, David Abramowitz","doi":"10.1177/22925503241265299","DOIUrl":"https://doi.org/10.1177/22925503241265299","url":null,"abstract":"Introduction: Penile amputation is a rare urological emergency with varying etiologies, ranging from psychiatric disorders to traumatic injuries, and requires precise microsurgical replantation techniques to restore function and appearance. The popularization of microsurgery has greatly improved outcomes by enabling accurate vascular and nerve reattachments, which are crucial for erectile function and sensation. This comprehensive study reviews advancements in microsurgical penile replantation, perioperative, and postoperative care, focusing on the nuances of surgical interventions and potential complications such as ischemia and necrosis. Methods: The PubMed, EMBASE, and Cochrane databases, were queried for studies published between 2015 and 2023 that discussed preoperative conditions, surgical techniques, and postoperative outcomes in penile replantation cases. Resulting studies that reported preoperative and postoperative outcomes of at least one case of penile replantation after amputation were included. Case parameters of interest were then extracted and categorized to determine the most common complications as well as solutions utilized in penile replantation. Results: Our findings from 46 cases across 37 studies revealed a common occurrence of postoperative necrosis (56.5%) and highlighted the importance of timely vascular reconnection and innovative surgical strategies to manage complications. Three cases were complicated by scrotal hematomas and 23 cases reported at least one psychiatric comorbidity. Some innovative solutions mentioned include hyperbaric oxygen therapy, laser angiography, leech therapy, PDE inhibitors, and penile splints. Conclusion: The outcomes suggest a critical need for standardized protocols and further research into optimizing techniques and therapies to enhance the success rates as well as quality of life post-replantation. This review aims to guide future practices and encourage collaborative efforts to refine the complex microsurgical procedures involved in penile replantation.","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141782669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-23DOI: 10.1177/22925503241263358
Amber Park, Phillip C. McKegg, William Brigode
Introduction: Soft tissue flaps are an integral and versatile tool to help manage soft tissue defects of varying severities. These complex procedures can be done by a variety of specialties and can lead to a variety of postoperative complications. Locoregional flaps are the middle rung of the reconstructive ladder and can be performed by surgeons of various training pathways. The profile of patients and their complications when stratified by surgical specialty is unknown. The purpose of this study was to compare short-term postoperative outcomes between surgical subspecialists performing a locoregional flap of the lower extremity to determine factors influencing complication rates. Methods: The National Surgical Quality Improvement Project (NSQIP) database was queried using Current Procedural Terminology code 15,738 to identify adult patients undergoing a muscle, myocutaneous, or fasciocutaneous lower extremity flap procedure from 2016 to 2019. We examined the primary outcome of a pooled wound complication rate with secondary outcomes including the individual NSQIP wound- and nonwound complications. Results: A total of 1324 patients were identified. Plastic surgeons performed 926 (70%) procedures, general surgeons performed 243 (18%) procedures, orthopedic surgeons performed 89 (7%) procedures, and vascular surgeons performed 66 (5%) procedures. On multivariate analysis, surgical subspecialty was not associated with the primary outcome, but malignancy-related operations and nonelective status were considered significant. Conclusions: Patient characteristics, but not surgeon subspecialty, account for the variation in patient outcomes in lower extremity flap reconstruction. Larger, prospective studies examining these outcomes are needed to further characterize complication risk factors in this patient population.
{"title":"Are There Differences in Short-Term Postoperative Outcomes Among Surgical Subspecialists Performing Lower Extremity Flap Procedures? A National Surgical Quality Improvement Project (NSQIP) Analysis of 1324 Patients","authors":"Amber Park, Phillip C. McKegg, William Brigode","doi":"10.1177/22925503241263358","DOIUrl":"https://doi.org/10.1177/22925503241263358","url":null,"abstract":"Introduction: Soft tissue flaps are an integral and versatile tool to help manage soft tissue defects of varying severities. These complex procedures can be done by a variety of specialties and can lead to a variety of postoperative complications. Locoregional flaps are the middle rung of the reconstructive ladder and can be performed by surgeons of various training pathways. The profile of patients and their complications when stratified by surgical specialty is unknown. The purpose of this study was to compare short-term postoperative outcomes between surgical subspecialists performing a locoregional flap of the lower extremity to determine factors influencing complication rates. Methods: The National Surgical Quality Improvement Project (NSQIP) database was queried using Current Procedural Terminology code 15,738 to identify adult patients undergoing a muscle, myocutaneous, or fasciocutaneous lower extremity flap procedure from 2016 to 2019. We examined the primary outcome of a pooled wound complication rate with secondary outcomes including the individual NSQIP wound- and nonwound complications. Results: A total of 1324 patients were identified. Plastic surgeons performed 926 (70%) procedures, general surgeons performed 243 (18%) procedures, orthopedic surgeons performed 89 (7%) procedures, and vascular surgeons performed 66 (5%) procedures. On multivariate analysis, surgical subspecialty was not associated with the primary outcome, but malignancy-related operations and nonelective status were considered significant. Conclusions: Patient characteristics, but not surgeon subspecialty, account for the variation in patient outcomes in lower extremity flap reconstruction. Larger, prospective studies examining these outcomes are needed to further characterize complication risk factors in this patient population.","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141782675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-31DOI: 10.1177/22925503241252241
Jennifer Matthews, Sophocles Voineskos
{"title":"Groupe pour l’Avancement de la Microchirurgie Canada (GAM)","authors":"Jennifer Matthews, Sophocles Voineskos","doi":"10.1177/22925503241252241","DOIUrl":"https://doi.org/10.1177/22925503241252241","url":null,"abstract":"","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141188858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-29DOI: 10.1177/22925503241256654
Tara Behroozian, Evan Fang, James Douketis, Helene Retrouvey, Achilles Thoma
Introduction: Given the aging population, plastic surgeons are increasingly faced with the challenge of balancing procedural bleeding risk with thromboembolic risk in patients receiving antithrombotic therapies undergoing elective procedures. Guideline recommendations remain unclear in this population, which contributes to heterogeneity in clinical practices. We present a practical approach that summarizes guideline recommendations to facilitate the perioperative management of patients requiring surgery who are already on antithrombotic agents. Methods: Due to the scarcity of plastic surgery-specific guidelines, recommendations were primarily adapted from the 2022 American College of Chest Physicians guidelines on perioperative management of antithrombotic therapy as they are recognized as authoritative and widely used in clinical practice. Results: A clinical practice conceptual framework was adapted based on preexisting guidelines, dividing decision-making into 3 steps: (1) assessing the procedural bleeding risk; (2) assessing the patients’ thromboembolic risk; and (3) determining appropriate management according to antithrombotic agent type. Specific indications are provided for continuing, stopping, and bridging anticoagulants and antiplatelet agents, as well as for consultation with a cardiologist or hematologist. Conclusion: The present framework can be implemented in plastic surgeons’ clinical practice to guide the management of patients on antithrombotic therapies, while minimizing nonessential referrals to the thrombosis service. The lack of plastic surgery-specific guidelines on this topic highlights a need for further research to “bootstrap” the risk categorization of plastic surgical procedures and their appropriate perioperative management.
{"title":"Perioperative Management of Antithrombotic Therapy in Patients Undergoing Plastic and Reconstructive Surgery: A Practical Tool Based on Current Guidelines","authors":"Tara Behroozian, Evan Fang, James Douketis, Helene Retrouvey, Achilles Thoma","doi":"10.1177/22925503241256654","DOIUrl":"https://doi.org/10.1177/22925503241256654","url":null,"abstract":"Introduction: Given the aging population, plastic surgeons are increasingly faced with the challenge of balancing procedural bleeding risk with thromboembolic risk in patients receiving antithrombotic therapies undergoing elective procedures. Guideline recommendations remain unclear in this population, which contributes to heterogeneity in clinical practices. We present a practical approach that summarizes guideline recommendations to facilitate the perioperative management of patients requiring surgery who are already on antithrombotic agents. Methods: Due to the scarcity of plastic surgery-specific guidelines, recommendations were primarily adapted from the 2022 American College of Chest Physicians guidelines on perioperative management of antithrombotic therapy as they are recognized as authoritative and widely used in clinical practice. Results: A clinical practice conceptual framework was adapted based on preexisting guidelines, dividing decision-making into 3 steps: (1) assessing the procedural bleeding risk; (2) assessing the patients’ thromboembolic risk; and (3) determining appropriate management according to antithrombotic agent type. Specific indications are provided for continuing, stopping, and bridging anticoagulants and antiplatelet agents, as well as for consultation with a cardiologist or hematologist. Conclusion: The present framework can be implemented in plastic surgeons’ clinical practice to guide the management of patients on antithrombotic therapies, while minimizing nonessential referrals to the thrombosis service. The lack of plastic surgery-specific guidelines on this topic highlights a need for further research to “bootstrap” the risk categorization of plastic surgical procedures and their appropriate perioperative management.","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141188943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-29DOI: 10.1177/22925503241255142
Shurjeel Uddin Qazi, Sarah Aman, Muhammad Hassaan Wajid, Zainab Qayyum, Muhammad Bilal Shahid, Alina Tanvir, Sania Javed, Mahnoor Saeed, Eesha Razia, Alina Nayyar, Osama Abdur Rehman, Faisal Khosa
Background: In the past few decades, there has been a gradual increase in breast reconstruction post mastectomy; however, there exists a conflict about whether race has an influence on reconstruction rates. Methods: We conducted an electronic search from MEDLINE and Cochrane CENTRAL from their inception to September 2022. Primary outcome was disparity in rates of Immediate Breast Reconstruction (IBR) in racial minorities. Odds ratios were pooled using a random-effects model. All statistical analyses were performed on the Review Manager. Quality of included studies was assessed using the Joanna Briggs Institute critical appraisal checklist. Results: Twenty studies ( n = 1 840 671) were identified. The pooled analysis of all the studies showed that subjects in racial minorities were significantly less likely to receive IBR as compared to White subjects (OR = 0.62, [95% confidence interval: 0.57-0.68; P < .01, I2 = 97%]. Subgroup analyses revealed that Asian subjects were the least likely to undergo IBR among different minorities (OR = 0.43). Conclusion: There exists a significant disparity in rates of IBR in different racial minorities as compared to White subjects. Future studies are warranted to assess factors contributing to such disparities in provision of healthcare.
{"title":"Racial Disparities in Immediate Breast Reconstruction after Mastectomy: A Systematic Review and Meta-Analysis","authors":"Shurjeel Uddin Qazi, Sarah Aman, Muhammad Hassaan Wajid, Zainab Qayyum, Muhammad Bilal Shahid, Alina Tanvir, Sania Javed, Mahnoor Saeed, Eesha Razia, Alina Nayyar, Osama Abdur Rehman, Faisal Khosa","doi":"10.1177/22925503241255142","DOIUrl":"https://doi.org/10.1177/22925503241255142","url":null,"abstract":"Background: In the past few decades, there has been a gradual increase in breast reconstruction post mastectomy; however, there exists a conflict about whether race has an influence on reconstruction rates. Methods: We conducted an electronic search from MEDLINE and Cochrane CENTRAL from their inception to September 2022. Primary outcome was disparity in rates of Immediate Breast Reconstruction (IBR) in racial minorities. Odds ratios were pooled using a random-effects model. All statistical analyses were performed on the Review Manager. Quality of included studies was assessed using the Joanna Briggs Institute critical appraisal checklist. Results: Twenty studies ( n = 1 840 671) were identified. The pooled analysis of all the studies showed that subjects in racial minorities were significantly less likely to receive IBR as compared to White subjects (OR = 0.62, [95% confidence interval: 0.57-0.68; P < .01, I<jats:sup>2</jats:sup> = 97%]. Subgroup analyses revealed that Asian subjects were the least likely to undergo IBR among different minorities (OR = 0.43). Conclusion: There exists a significant disparity in rates of IBR in different racial minorities as compared to White subjects. Future studies are warranted to assess factors contributing to such disparities in provision of healthcare.","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141189191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-13DOI: 10.1177/22925503241249757
Kaitlyn M. Enright, John S. Sampalis, Anneke Andriessen, Andreas Nikolis
Introduction: Research in aesthetic medicine commonly includes evaluations of subject satisfaction with treatment results. However, conventional analytic methods typically generate statistically imprecise ordinal scores. To overcome this limitation, researchers have begun employing the Rasch model, an analytical framework grounded in item response theory. The Rasch model permits scale modifications capable of enhancing measurement accuracy. This study focuses on using the Rasch model to evaluate a scale measuring subject satisfaction following aesthetic treatments to the jawline. Objective: To develop and validate a multiitem, self-administered questionnaire measuring patient satisfaction with aesthetic treatment of the jawline. Methods: A 10-item questionnaire [The Jawline Subject Satisfaction Scale (JS3)] was devised to measure subject satisfaction following aesthetic treatments of the jawline. Each question was responded to using a 5-point Likert scale, with response selections ranging from “very much satisfied” to “very much dissatisfied” or “strongly agree” to “strongly disagree.” The scale's psychometric properties (reliability and separation for items and persons, item and person fit statistics, and unidimensionality and local independence) were validated using a Rasch model based on a dataset collected from a sample of forty subjects. Results: The results of the Rasch analysis revealed high internal consistency of the JS3, with a person reliability estimate of 0.86 and an item reliability estimate of 0.96. The separation estimates for persons and items were 2.50 and 4.72, respectively, demonstrating the scale's ability to differentiate between high and low responders and validating the instrument's construct. All infit and outfit values fell within the established range (0.5-1.5), and the data fit the model of unidimensionality and local independence. Raw score transformations into logits were conducted, which were then converted to Rasch measurements. These measurements are available for use in practice for conducting standard statistical analyses evaluating treatment and/or group effects. Conclusions: The application of the Rasch model produced a valid and reliable scale (ie, JS3) for measuring satisfaction with the appearance of the jawline following aesthetic treatments.
{"title":"Development and Validation of the Jawline Subject Satisfaction Scale","authors":"Kaitlyn M. Enright, John S. Sampalis, Anneke Andriessen, Andreas Nikolis","doi":"10.1177/22925503241249757","DOIUrl":"https://doi.org/10.1177/22925503241249757","url":null,"abstract":"Introduction: Research in aesthetic medicine commonly includes evaluations of subject satisfaction with treatment results. However, conventional analytic methods typically generate statistically imprecise ordinal scores. To overcome this limitation, researchers have begun employing the Rasch model, an analytical framework grounded in item response theory. The Rasch model permits scale modifications capable of enhancing measurement accuracy. This study focuses on using the Rasch model to evaluate a scale measuring subject satisfaction following aesthetic treatments to the jawline. Objective: To develop and validate a multiitem, self-administered questionnaire measuring patient satisfaction with aesthetic treatment of the jawline. Methods: A 10-item questionnaire [The Jawline Subject Satisfaction Scale (JS<jats:sup>3</jats:sup>)] was devised to measure subject satisfaction following aesthetic treatments of the jawline. Each question was responded to using a 5-point Likert scale, with response selections ranging from “very much satisfied” to “very much dissatisfied” or “strongly agree” to “strongly disagree.” The scale's psychometric properties (reliability and separation for items and persons, item and person fit statistics, and unidimensionality and local independence) were validated using a Rasch model based on a dataset collected from a sample of forty subjects. Results: The results of the Rasch analysis revealed high internal consistency of the JS<jats:sup>3</jats:sup>, with a person reliability estimate of 0.86 and an item reliability estimate of 0.96. The separation estimates for persons and items were 2.50 and 4.72, respectively, demonstrating the scale's ability to differentiate between high and low responders and validating the instrument's construct. All infit and outfit values fell within the established range (0.5-1.5), and the data fit the model of unidimensionality and local independence. Raw score transformations into logits were conducted, which were then converted to Rasch measurements. These measurements are available for use in practice for conducting standard statistical analyses evaluating treatment and/or group effects. Conclusions: The application of the Rasch model produced a valid and reliable scale (ie, JS<jats:sup>3</jats:sup>) for measuring satisfaction with the appearance of the jawline following aesthetic treatments.","PeriodicalId":20206,"journal":{"name":"Plastic surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140926594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号